There's a citizen petition sitting on the FDA's desk right now that proposes creating a federal registry of trans women who are prescribed estrogen. It's buried in the regulatory weeds of regulations.gov, dressed in clinical language about "Risk Evaluation and Mitigation Strategies," and it's counting on the fact that most people don't read citizen petitions.
The petition was filed by a coalition of fifteen organizations -- most of which didn't exist before 2024, several of which appear to be linked to each other or to the same parent groups. The Needle published a thorough investigation of the petition, its signatories, and the evidence it cites. The primary research supporting it was co-authored by people affiliated with organizations that the Southern Poverty Law Center has designated as hate groups.
This petition asks the FDA to do the following:
- Create a patient registry of every trans woman prescribed estrogen. Not a study. Not an opt-in research cohort. A government list of a targeted minority, maintained by name.
- Require mandatory psychological evaluations before estrogen can be prescribed to trans patients. Not for all women taking the medication for any number of reasons, just for trans women.
- Attach a "dangerous drug" warning label to estrogen, but only when prescribed for gender-affirming care. The same compound, prescribed to a cis woman for menopause, wouldn't carry the warning.
- Add estrogen to the FDA's adverse event reporting system (FAERS), which accepts anonymous, unverified reports and -- as we learned during COVID with the analogous VAERS database -- can be weaponized with junk data by anyone with a keyboard and a grudge.
- Replace informed consent with a gatekeeping model where a third-party psychologist must approve your access to medication. Again, only for trans patients.
A rose by any other name may smell as sweet. This, whatever they're calling it, reeks.
An outright ban would be loud. It would generate headlines, legal challenges, and immediate public opposition. This petition is doing something quieter and, in the long run, more insidious. It's building surveillance infrastructure.
A registry doesn't technically prevent anyone from getting care. It just ensures the government knows exactly who's getting it. Mandatory evaluations don't technically deny access. They just add a gatekeeper who can. Warning labels don't technically restrict prescribing. They just create liability pressure that makes doctors think twice.
Each piece, taken individually, sounds almost reasonable if you don't look too closely. Taken together, they construct a system where trans people are tracked, surveilled, gatekept, and deterred from seeking care -- all while the government can claim it never banned anything. History has a word for this approach. Several words, actually. None of them are kind.
I've watched people I love navigate a medical system that, until recently, treated them with basic dignity. Informed consent -- the principle that a competent adult can make decisions about their own body after being told the risks -- isn't some radical experiment. It's the foundation of modern medical ethics. It applies to everyone, or it applies to no one.
The Fourth and Fourteenth Amendments exist precisely to prevent the government from singling out a class of citizens for surveillance and control without compelling justification. A registry of people who take a naturally occurring hormone -- one that exists in virtually every adult human body -- is not a compelling medical safety measure. It's a political tool.
And the equal protection problem is glaring. If estrogen is dangerous enough to require a registry and psychological gatekeeping for trans women, why isn't it dangerous enough to require the same for menopausal cis women? The answer, of course, is that it isn't about safety. It never was.
This petition will probably fail. Historically, about 93% of FDA citizen petitions are denied. But "probably" is doing a lot of work in that sentence, and the current political environment makes predictions less reliable than usual.
Even if the petition itself goes nowhere, the playbook it represents -- surveillance dressed as safety, gatekeeping dressed as caution, discrimination dressed in clinical language -- doesn't go away. It just gets filed and refined and resubmitted. The people behind this have time, funding, and a coordinated strategy. What they don't have, yet, is an opposition that shows up in the regulatory spaces where these fights actually get decided.
Regulations.gov isn't Twitter. It's boring, bureaucratic, and obscure. That's exactly why it matters. As of the original Needle reporting, every viewable public comment on this petition was in support of it. The opposition hasn't shown up yet, and the comment period is still open.